SCHEMBL3268764

SCHEMBL3268764

Cc1cc(OCCCBr)c2ccc(F)cc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
NCF1 P14598 6/20 0.38
PDE10A Q9Y233 1/20 0.36
KCNH2 Q12809 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MPO P05164 1/20 0.35
S1PR4 O95977 1/20 0.35
HTR1A P08908 3/20 0.35
HTR1D P28221 3/20 0.35
ADRB1 P08588 2/20 0.35
DRD2 P14416 2/20 0.35
HTR1B P28222 2/20 0.35
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35
HTR7 P34969 2/20 0.35
DRD3 P35462 2/20 0.35
HTR2B P41595 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5341791 0.83 HTR1D (0.41) NCF1S1PR4HTR1AHTR1DADRB1
SCHEMBL3268831 0.81 NCF1 (0.52) KDM4ENCF1
SCHEMBL3268686 0.75 DHFR (0.50) NCF1
SCHEMBL2614815 0.74 KDM4E (0.47) KDM4EHSD17B10PDE10AKCNH2SMN1; SMN2
Hydrochloric Acid SCHEMBL3266898 0.74 DHFR (0.51) NCF1
SCHEMBL20684324 0.72 MRGPRX4 (0.43) KDM4ESMN1; SMN2ALDH1A1
SCHEMBL5348697 0.70 S1PR4 (0.46) NCF1S1PR4HTR1AHTR1DADRB1
SCHEMBL14960133 0.70 POLB (0.61) KDM4EMPOMAPK1ALDH1A1
SCHEMBL3271599 0.70 IDO1 (0.43) HTR1A
SCHEMBL8676178 0.69 CCR1 (0.42) KDM4ESMN1; SMN2S1PR4HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546452-A1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS MMV Medicines for Malaria Venture (CH) 2019-10-02 EP disclosed
EP-2194985-B1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS MEDICINES FOR MALARIA VENTURE MMV (CH) 2019-02-20 EP disclosed
US-8530491-B2 Antimalarial compounds with flexible side-chains MEDICINES FOR MALARIA VENTURE (MMV) (CH) 2013-09-10 US disclosed
EP-2194985-A1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS Medicines for Malaria Venture (CH) 2010-06-16 EP disclosed
US-20090099220-A1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS MEDICINES FOR MALARIA VENTURE 2009-04-16 US disclosed
WO-2009048957-A1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS MEDICINES FOR MALARIA VENTURE (CH) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099220-A1 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS DHFR, FPGS, DHODH KDM4E 1048/4885HSD17B10 428/4885NCF1 2427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.